These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2039015)

  • 61. Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension.
    Heran BS; Chen JM; Wang JJ; Wright JM
    Cochrane Database Syst Rev; 2010 Jan; (1):CD008167. PubMed ID: 20091662
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Investigational calcium channel blockers for the treatment of hypertension.
    Tamargo J; Ruilope LM
    Expert Opin Investig Drugs; 2016 Nov; 25(11):1295-1309. PubMed ID: 27696904
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antihypertensive medication use and blood pressure control: a community-based cross-sectional survey (ON-BP).
    McInnis NH; Fodor G; Moy Lum-Kwong M; Leenen FH
    Am J Hypertens; 2008 Nov; 21(11):1210-5. PubMed ID: 18772857
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
    Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
    Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R; Michailidis P
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antihypertensive drugs and fibrinolytic function.
    Fogari R; Zoppi A
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effects of calcium antagonists on electrolytes and water balance in hypertensive patients.
    Leonetti G
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S25-9. PubMed ID: 7603074
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The place of the calcium antagonist verapamil in antihypertensive therapy.
    Bühler FR; Hulthén UL; Kiowski W; Müller FB; Bolli P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S350-7. PubMed ID: 6184567
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Equivalent antihypertensive effects of combination therapy using diuretic + calcium antagonist compared with diuretic + ACE inhibitor.
    Elliott WJ; Polascik TB; Murphy MB
    J Hum Hypertens; 1990 Dec; 4(6):717-23. PubMed ID: 2096214
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of N- and T-type calcium channel blocker on proteinuria, blood pressure and kidney function in hypertensive patients: a meta-analysis.
    Thamcharoen N; Susantitaphong P; Wongrakpanich S; Chongsathidkiet P; Tantrachoti P; Pitukweerakul S; Avihingsanon Y; Praditpornsilpa K; Jaber BL; Eiam-Ong S
    Hypertens Res; 2015 Dec; 38(12):847-55. PubMed ID: 26134125
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
    Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
    Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Proposal of RAS-diuretic vs. RAS-calcium antagonist strategies in high-risk hypertension: insight from the 24-hour ambulatory blood pressure profile and central pressure.
    Kario K
    J Am Soc Hypertens; 2010; 4(5):215-8. PubMed ID: 20728424
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of dietary potassium in the treatment of hypertension.
    Treasure J; Ploth D
    Hypertension; 1983; 5(6):864-72. PubMed ID: 6360869
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: blood pressure control and immunosuppression.
    Weir MR
    Am J Med; 1991 May; 90(5A):32S-36S. PubMed ID: 2039018
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The diuretic effect of calcium entry blockade in normals and hypertensive patients.
    Geyskes GG; Van Schaik BA; Gaillard CA; Koomans HA
    Tohoku J Exp Med; 1992 Jan; 166(1):135-46. PubMed ID: 1412440
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Diuretics, sodium intake, and renin in the management of hypertension.
    Swales JD; Bing RF; Swart S; Thurston H
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S250-5. PubMed ID: 6204150
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Calcium entry blockers in the treatment of hypertension. Current status and future prospects.
    Kaplan NM
    JAMA; 1989 Aug; 262(6):817-23. PubMed ID: 2664242
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of sodium intake in the antihypertensive effect of propranolol.
    Owens CJ; Brackett NC
    South Med J; 1978 Jan; 71(1):43-6. PubMed ID: 622601
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sodium is more important than calcium in essential hypertension.
    MacGregor GA
    Hypertension; 1985; 7(4):628-40. PubMed ID: 4007994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.